Zafgen (ZFGN) Tops Q4 EPS by 36c

Go back to Zafgen (ZFGN) Tops Q4 EPS by 36c

Zafgen (ZFGN) PT Lifted to $58 at RBC Capital Despit bestPWS Phase III Being Pushed Out a Bit

March 20, 2015 11:06 AM EDT

RBC Capital analyst Simos Simeonidis reiterated an Outperform rating and boosted his price target on Zafgen (NASDAQ: ZFGN) to $58.00 (from $53.00) following Q4 results and despite PWS Phase III data being pushed out a bit.

Simeonidis commented, "On its 4Q14 call, ZFGN... More

Zafgen (ZFGN) PT Raised to $60 at Cowen

March 20, 2015 9:08 AM EDT

Cowen analyst Phil Nadeau reiterated an Outperform rating and lifted his price target on Zafgen (NASDAQ: ZFGN) to $60.00 (from $45.00) following Q4 results. The analyst also notes Data from Beloranib's PWS Ph. III is expected in Q2:16.

Nadeau commented, "Data from... More

Zafgen (ZFGN) PT Raised to $61 at Leerink Partners Post Q4

March 20, 2015 7:00 AM EDT

Leerink Partners analyst Joseph Schwartz reiterated an Outperform rating and lifted his price target on Zafgen (NASDAQ: ZFGN) to $61.00 (from $42.00) after the company reported 4Q14 EPS of ($0.48) which was better than the firm's estimate of ($0.81).

Schwartz commented, "We are updating our model to... More